ROCKET PHARMACEUTICALS, INC. Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ROCKET PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ROCKET PHARMACEUTICALS, INC. for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Pitango Venture Capital Princi ... | 10% Owner | Option Exercise | C | 0.00 | 225,747 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Pitango Venture Capital Princi ... | 10% Owner | Option Exercise | C | 0.00 | 2,676,348 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Pitango Venture Capital Princi ... | 10% Owner | Buy | P | 6.00 | 212,375 | 1,274,250 | 1,292,584 | 1.1 M to 1.3 M (+19.66 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Pitango Venture Capital Princi ... | 10% Owner | Buy | C | 0.00 | 38,143 | 0 | 1,080,209 | 1 M to 1.1 M (+3.66 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Pitango Venture Capital Princi ... | 10% Owner | Buy | C | 0.00 | 847,424 | 0 | 1,042,066 | 194.6 K to 1 M (+435.38 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | KARABELAS ARGERIS N | Director | Option Exercise | C | 0.00 | 4,459,658 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | KARABELAS ARGERIS N | Director | Buy | P | 6.00 | 603,832 | 3,622,992 | 2,277,139 | 1.7 M to 2.3 M (+36.09 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | KARABELAS ARGERIS N | Director | Buy | C | 0.00 | 63,560 | 0 | 1,673,307 | 1.6 M to 1.7 M (+3.95 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | KARABELAS ARGERIS N | Director | Buy | C | 0.00 | 1,394,645 | 0 | 1,609,747 | 215.1 K to 1.6 M (+648.36 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | CARE CAPITAL II LLC | 10% Owner | Option Exercise | C | 0.00 | 4,459,658 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | CARE CAPITAL II LLC | 10% Owner | Buy | P | 6.00 | 603,832 | 3,622,992 | 2,277,139 | 1.7 M to 2.3 M (+36.09 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | CARE CAPITAL II LLC | 10% Owner | Buy | C | 0.00 | 63,560 | 0 | 1,673,307 | 1.6 M to 1.7 M (+3.95 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | CARE CAPITAL II LLC | 10% Owner | Buy | C | 0.00 | 1,394,645 | 0 | 1,609,747 | 215.1 K to 1.6 M (+648.36 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | RHO VENTURES IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 432,591 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | RHO VENTURES IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 5,128,577 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | RHO VENTURES IV QP LP | 10% Owner | Buy | P | 6.00 | 958,226 | 5,749,356 | 2,870,584 | 1.9 M to 2.9 M (+50.11 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | RHO VENTURES IV QP LP | 10% Owner | Buy | C | 0.00 | 73,092 | 0 | 1,912,358 | 1.8 M to 1.9 M (+3.97 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | RHO VENTURES IV QP LP | 10% Owner | Buy | C | 0.00 | 1,606,230 | 0 | 1,839,266 | 233 K to 1.8 M (+689.26 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Kantesaria Devang | 10% Owner | Option Exercise | C | 0.00 | 626,943 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Kantesaria Devang | 10% Owner | Option Exercise | C | 0.00 | 7,432,720 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Kantesaria Devang | 10% Owner | Buy | P | 6.00 | 814,166 | 4,884,996 | 3,243,709 | 2.4 M to 3.2 M (+33.51 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Kantesaria Devang | 10% Owner | Buy | C | 0.00 | 105,933 | 0 | 2,429,543 | 2.3 M to 2.4 M (+4.56 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Kantesaria Devang | 10% Owner | Buy | C | 0.00 | 2,323,610 | 0 | 2,323,610 | 0 to 2.3 M |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | DEVON PARK BIOVENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 626,943 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | DEVON PARK BIOVENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 7,432,720 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | DEVON PARK BIOVENTURES LP | 10% Owner | Buy | P | 6.00 | 814,166 | 4,884,996 | 3,243,709 | 2.4 M to 3.2 M (+33.51 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | DEVON PARK BIOVENTURES LP | 10% Owner | Buy | C | 0.00 | 105,933 | 0 | 2,429,543 | 2.3 M to 2.4 M (+4.56 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | DEVON PARK BIOVENTURES LP | 10% Owner | Buy | C | 0.00 | 2,323,610 | 0 | 2,323,610 | 0 to 2.3 M |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 338,551 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 4,013,692 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Buy | P | 6.00 | 416,667 | 2,500,002 | 1,917,906 | 1.5 M to 1.9 M (+27.75 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 57,204 | 0 | 1,501,239 | 1.4 M to 1.5 M (+3.96 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 1,255,123 | 0 | 1,444,035 | 188.9 K to 1.4 M (+664.40 %) |